Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double - Blind, Placebo Controlled Crossover Study to Evaluate The Efficacy and Tolerability of Stelara ™ (Ustekinumab) in The Treatment of Scalp Psoriasis

NCT01558310 is registered in ClinicalTrials.gov with Paul Steven Yamauchi, MD, PhD as lead sponsor.

NCT NCT01558310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01558310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double - Blind, Placebo Controlled Crossover Study to Evaluate The Efficacy and Tolerability of Stelara ™ (Ustekinumab) in The Treatment of Scalp Psoriasis
Lead sponsor
Paul Steven Yamauchi, MD, PhD
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2012
Completion date
December 31, 2013
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis, scalp psoriasis